Yahoo Web Search

Search results

  1. www.lonza.com › about-us › our-locationsSingapore, Tuas | Lonza

    Lonza Singapore is a mammalian cell culture and cell and gene therapy CDMO of biopharmaceutical products, including monoclonal antibodies (mAbs), cellular therapeutics and other recombinant proteins.

  2. www.lonza.com › about-usAbout Us | Lonza

    Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market.

  3. www.lonza.com › careersCareers | Lonza

    4 days ago · Find your job opportunity at Lonza and become part of our global teams. Submit your application now and get one step closer to making a meaningful...

  4. Oct 11, 2021 · Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics.

  5. Oct 7, 2021 · Lonza's expansion in Singapore will establish additional capacity for cell culture, purification, and analytical services for biologics.

  6. www.linkedin.com › company › lonzaLonza | LinkedIn

    Lonza | 319,742 followers on LinkedIn. A Meaningful Difference for 125 Years | At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization.

  7. Dec 6, 2006 · Lonza and Bio*One Capital will build a large-scale mammalian cell culture facility in Singapore to manufacture commercial biopharmaceuticals, under a new joint venture, Lonza Biologics Tuas.

  8. www.moe.gov.sg › biomedical-and-pharmaceuticals › lonza-biologics-tuas-pte-ltdLonza Biologics Tuas Pte Ltd | MOE

    Jan 10, 2024 · Lonza Biologics Tuas Pte Ltd. https://www.lonza.com/about-us/our-locations/tuas-singapore. Lonza is a preferred global partner to the pharmaceutical, biotech, and nutrition markets, focusing on enabling treatments that prevent illness and support healthier lifestyles.

  9. Oct 21, 2011 · Singapore Exchange (“SGX”) is pleased that Lonza Group Ltd (“Lonza”), one of the world’s leading suppliers to the pharmaceutical, healthcare and life science industries, is listed today on its Mainboard by way of a secondary listing.

  10. Genentech exercised its option to buy Lonzas new 80,000-litre large-scale mammalian biologics manufacturing facility in Singapore for $290 million up front and potentially another $70 million...

  1. People also search for